Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors

Sensei Biotherapeutics, Inc.(NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next-generation therapeutics for cancer, today announced the appointment of William (Bill) Ringo, MBA, as chair of its Board of Directors...
Login to comment.